ngn1

Migration, Crosslink

📖

ngn1

active

wiki page Created: 2026-04-02T07:19:29 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ngn1

📖 Wiki Page

gene2073 wordssynced 2026-04-02

ngn1

Overview

NGN1 (Neurogenin-1), also known as NGN1 or NGN-1, is a Class A basic helix-loop-helix (bHLH) transcription factor encoded by the NGN1 gene located on chromosome 9q21.13. NGN1 plays critical and diverse roles in vertebrate nervous system development, including neural crest specification, sensory neuron differentiation, autonomic neuron development, and regulation of neural stem cells [1][5]. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration and peripheral nervous system disorders.

<div class="infobox infobox-gene">
<div class="infobox-header">NGN1 — Neurogenin-1</div>

| Property | Value |
|----------|-------|
| Gene Symbol | NGN1 |
| Full Name | Neurogenin-1 |
| Chromosomal Location | 9q21.13 |
| NCBI Gene ID | 4745 |
| OMIM ID | 604663 |
| Ensembl ID | ENSG00000166845 |
| UniProt ID | Q9Y4Z4 |
| Protein Length | 282 amino acids |
| Molecular Weight | ~30 kDa |
| Associated Diseases | Hirschsprung disease, peripheral neuropathy, Charcot-Marie-Tooth disease, chemotherapy-induced neuropathy |

</div>

Gene and Protein Structure

Gene Organization

...

ngn1

Overview

NGN1 (Neurogenin-1), also known as NGN1 or NGN-1, is a Class A basic helix-loop-helix (bHLH) transcription factor encoded by the NGN1 gene located on chromosome 9q21.13. NGN1 plays critical and diverse roles in vertebrate nervous system development, including neural crest specification, sensory neuron differentiation, autonomic neuron development, and regulation of neural stem cells [1][5]. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration and peripheral nervous system disorders.

<div class="infobox infobox-gene">
<div class="infobox-header">NGN1 — Neurogenin-1</div>

| Property | Value |
|----------|-------|
| Gene Symbol | NGN1 |
| Full Name | Neurogenin-1 |
| Chromosomal Location | 9q21.13 |
| NCBI Gene ID | 4745 |
| OMIM ID | 604663 |
| Ensembl ID | ENSG00000166845 |
| UniProt ID | Q9Y4Z4 |
| Protein Length | 282 amino acids |
| Molecular Weight | ~30 kDa |
| Associated Diseases | Hirschsprung disease, peripheral neuropathy, Charcot-Marie-Tooth disease, chemotherapy-induced neuropathy |

</div>

Gene and Protein Structure

Gene Organization

The NGN1 gene is located on chromosome 9q21.13 (GRCh38: chr9:71,847,759-71,852,131) and spans approximately 4.4 kb of genomic DNA. The gene consists of 3 exons encoding a 282-amino acid protein with a molecular weight of approximately 30 kDa [1]. Alternative splicing generates multiple transcript variants with different 5' and 3' UTRs, allowing for context-dependent regulation.

Protein Domain Architecture

NGN1 contains several distinct functional domains characteristic of Class I bHLH transcription factors:

N-terminal Domain (residues 1-100):

Transcriptional activation domain: Rich in acidic residues
Protein-protein interaction sites: For dimer formation

Basic Helix-Loop-Helix Domain (residues 101-167):

Basic region: DNA-binding domain that recognizes E-box consensus sequence (CANNTG)
HLH region: Dimerization domain forming homodimers or heterodimers with other bHLH factors

C-terminal Domain (residues 168-282):

Tertiary structure: Stabilizes protein-DNA interactions
Regulatory motifs: Post-translational modification sites

Structural Features

The bHLH domain is evolutionarily conserved and mediates:

Sequence-specific DNA binding to E-box elements
Dimerization with other bHLH proteins (e.g., E2A, E2-2, HES family)
Nuclear localization and transcriptional activation

Normal Function

Neural Crest Development

NGN1 is a master regulator of neural crest specification [1][5][19]:

Specification Mechanism:

Neural plate border specification by BMP and Wnt signaling

NGN1 activation in neural plate border cells

Upregulation of neural crest markers (SOX10, FOXD3, PAX7)

Delamination and migration of neural crest progenitors

Fate Determination:
NGN1 promotes neural crest cells to adopt a neuronal rather than melanocytic fate [5][19]:

Drives differentiation toward peripheral neurons
Represses melanocyte lineage genes
Cooperates with other transcription factors (SOX10, PAX3)

Sensory Neuron Differentiation

NGN1 is essential for sensory neuron subtype specification [2][8][12]:

Sensory Neuron Subtypes:

Thermoreceptors: Temperature sensing neurons
Mechanoreceptors: Touch and vibration sensing neurons
Nociceptors: Pain sensing neurons
Proprioceptors: Position and movement sensing neurons

Trk Receptor Expression:
NGN1 regulates expression of neurotrophin receptors:

TrkA (NTRK1): High-affinity NGF receptor
TrkB (NTRK2): BDNF/NT-3 receptor
TrkC (NTRK3): NT-3 receptor

This allows target-derived neurotrophin support for specific sensory neuron populations.

Autonomic Nervous System Development

NGN1 plays critical roles in autonomic neuron development [4][15]:

Sympathetic Neuron Development:

Promotes sympathetic ganglionic neuron differentiation
Controls noradrenergic phenotype specification
Regulates synaptic connectivity
Guides target innervation

Enteric Nervous System:

Essential for enteric neuron development [15]
Regulates migration of enteric neural crest cells
Controls differentiation of various enteric neuron subtypes
Critical for Hirschsprung disease when mutated

Adult Neurogenesis

In the adult brain, NGN1 continues to play roles [9]:

Neural Stem Cell Regulation:

Maintains neural stem/progenitor cell pools
Promotes neuronal differentiation
Regulates synaptic plasticity
Supports cognitive function

Activity-Dependent Expression:

NGN1 expression is regulated by neuronal activity
Responds to environmental enrichment
Modulated by learning and memory tasks

Expression Patterns

Developmental Expression

NGN1 exhibits dynamic spatiotemporal expression during development [2][8]:

| Developmental Stage | Expression Pattern |
|---------------------|-------------------|
| E8.5-E10.5 | Neural plate border, neural crest |
| E10.5-E14.5 | Dorsal root ganglia, sympathetic ganglia |
| E14.5-P0 | Maturing sensory and autonomic neurons |
| Postnatal | Low in CNS, maintained in PNS |

Tissue Distribution

High Expression:

Dorsal root ganglia (sensory neurons)
Sympathetic ganglia (autonomic neurons)
Trigeminal ganglion (cranial sensory)
Enteric nervous system (gut innervation)

Moderate Expression:

Spinal cord (motor neurons)
Brain (specific interneuron populations)
Peripheral nerves

Low/No Expression:

Most CNS regions in adulthood
Non-neuronal tissues

Brain Region Specificity

In the central nervous system:

Cortex: Specific interneuron populations
Hippocampus: Dentate gyrus progenitors
Subventricular zone: Neural stem cells

Disease Associations

Neurodevelopmental Disorders

NGN1 dysfunction is linked to several neurodevelopmental conditions [3][6][10]:

Hirschsprung Disease:

Mutations in NGN1 associated with Hirschsprung disease [3]
Enteric nervous system defects
Aganglionic colon segments
Treatment requires surgical intervention

Peripheral Neuropathies:

Congenital sensory and autonomic neuropathy
Hereditary sensory and autonomic neuropathy (HSAN)
Developmental defects in peripheral sensory neurons [10][11]

Neurocristopathies:

Disorders arising from neural crest cell defects
Waardenburg syndrome (with PAX3 mutations)
Neuroblastoma predisposition

-CHARGE syndrome association

Neurodegeneration

While primarily studied in development, NGN1 has relevance to neurodegenerative conditions [10][11][14][18]:

Charcot-Marie-Tooth Disease:

NGN1 variants may modify disease severity
Role in maintaining peripheral nerve integrity
Therapeutic targeting being explored

Diabetic Neuropathy:

NGN1 expression affected by hyperglycemia [18]
Contributes to sensory neuron dysfunction
Potential therapeutic target

Chemotherapy-Induced Neuropathy:

NGN1 downregulation in chemotherapy-induced neuropathy [14]
Contributes to sensory neuron damage
Taxol, vincristine, and cisplatin effects

Chemotherapy-Induced Peripheral Neuropathy (CIPN):
Chemotherapeutic agents can cause peripheral neuropathy through multiple mechanisms that involve NGN1 dysregulation [14]:

Direct toxicity to dorsal root ganglion neurons
Disruption of axonal transport
Mitochondrial dysfunction
NGN1 expression changes

Regenerative Medicine

NGN1 has significant potential in regenerative approaches [13]:

Peripheral Nerve Regeneration:

NGN1 overexpression promotes nerve regeneration
Supports Schwann cell dedifferentiation
Enhances axonal outgrowth

Enteric Nervous System Repair:

NGN1-based therapies for Hirschsprung disease
Enteric neural crest cell transplantation
Tissue engineering approaches

Sensory Neuron Replacement:

In vitro differentiation of sensory neurons from stem cells
NGN1 as a key differentiation factor
Pain research and drug screening applications

Molecular Mechanisms

Transcriptional Regulation

NGN1 regulates gene expression through multiple mechanisms [1][5][8]:

Direct Target Genes:

Neurotrophin receptors: NTRK1, NTRK2, NTRK3
Ion channels: Nav1.7, Nav1.8, Nav1.9 (pain sensing)
Neuropeptides: Substantia P, CGRP
Synaptic proteins: Synapsin, Synaptophysin
Transcription factors: SOX10, FOXD3, PAX3

E-box Binding:
NGN1 binds to E-box consensus sequences (CANNTG) in target gene promoters:

CANNTG motifs in neuronal differentiation genes
Cooperative binding with other bHLH factors
Chromatin remodeling at target loci

Signaling Pathways

NGN1 activity is regulated by multiple signaling pathways:

BMP signaling → Neural plate border → NGN1 expression
↓
Wnt signaling → Enhances NGN1 activation
↓
Notch signaling → Cross-regulation with NGN1
↓
Neurotrophin signaling → Activity-dependent modulation

Key Pathways:

BMP: Induces neural crest specification
Wnt: Cooperates with BMP for neural crest induction
FGF: Maintains progenitor population
Notch: Lateral inhibition and cell fate decisions
Neurotrophin: Activity-dependent regulation

Protein Interactions

NGN1 interacts with various proteins:

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|------------------------|
| E2A (TCF3) | Dimerization | DNA binding |
| E2-2 (TCF4) | Dimerization | Target gene regulation |
| SOX10 | Cooperation | Neural crest genes |
| PAX3 | Cooperation | Migration genes |
| PAX7 | Cooperation | Specification |
| CBP/p300 | Co-activation | Histone acetylation |

Therapeutic Implications

NGN1 in Regenerative Medicine

Targeting NGN1 offers therapeutic opportunities [13]:

Gene Therapy Approaches:

AAV-mediated NGN1 delivery
CRISPR-based NGN1 activation
Small molecule NGN1 inducers

Cell-Based Therapies:

Neural crest cell transplantation
Enteric nervous system repair
Sensory neuron replacement

Small Molecule Modulators:

NGN1 expression enhancers
bHLH domain modulators
Neurotrophin pathway activators

Challenges and Considerations

Delivery to peripheral nervous system
Temporal control of expression
Cell-type specificity
Off-target effects
Safety concerns

Biomarker Potential

NGN1 expression may serve as a biomarker:

Disease progression in peripheral neuropathies
Treatment response in regenerative approaches
Toxicity markers in chemotherapy-induced neuropathy

Animal Models

Knockout Studies

Ngn1 knockout mice have been generated and exhibit:

Embryonic lethality (some lines): Severe neural crest defects
Peripheral nervous system defects: Absent dorsal root ganglia
Sensory neuron deficits: Loss of most sensory neurons
Enteric nervous system defects: Hirschsprung-like phenotype

Transgenic Models

Ngn1 overexpression studies demonstrate:

Ectopic neuronal differentiation: Neurons in non-neuronal tissues
Enhanced regeneration: Improved nerve repair
Enteric neuron expansion: Potential for gut disorders

Disease Models

In various disease models:

Diabetes models: NGN1 dysregulation in diabetic neuropathy
Chemotherapy models: NGN1 changes in CIPN
Regeneration models: Enhanced repair with NGN1

Genetic Variants

Known Polymorphisms

Several NGN1 variants have been identified:

Missense variants: Altered protein function
Regulatory variants: Changed expression levels
Splice variants: Altered isoforms

Disease Associations

Modifier of Hirschsprung disease severity
Risk factor for peripheral neuropathy
Potentially modifies neurodegenerative disease progression

Research Directions

Current Areas of Investigation

Understanding NGN1's specific roles in different neuronal cell types

Therapeutic targeting of NGN1 in peripheral neuropathies

Regenerative applications using NGN1

Biomarker development for disease progression

Gene therapy approaches

Future Perspectives

Personalized medicine approaches
Combination therapies
Stem cell-based treatments
Novel delivery systems

Summary

NGN1 (Neurogenin-1) is a critical Class A bHLH transcription factor encoded by the NGN1 gene on chromosome 9q21.13. This protein plays essential roles in vertebrate nervous system development, including neural crest specification, sensory neuron differentiation, and autonomic neuron development [1][5].

In neurodegeneration and peripheral nerve disorders, NGN1 is relevant through:

Peripheral neuropathies: NGN1 variants associated with Charcot-Marie-Tooth and other neuropathies [10][11]
Chemotherapy-induced neuropathy: NGN1 downregulation contributes to sensory neuron damage [14]
Diabetic neuropathy: NGN1 expression affected by hyperglycemia [18]
Regenerative medicine: NGN1 overexpression promotes nerve regeneration [13]

The gene represents a promising therapeutic target, with ongoing research focusing on NGN1-based regenerative approaches, gene therapy, and small molecule modulators. Understanding NGN1 biology continues to reveal new opportunities for treating peripheral nervous system disorders and advancing regenerative medicine.

Key Takeaways

NGN1 is a master regulator of neural crest and sensory neuron development

The protein belongs to Class I bHLH transcription factors

NGN1 regulates neurotrophin receptor expression for target-derived support

Mutations cause Hirschsprung disease and peripheral neuropathies

NGN1 has significant potential in regenerative medicine

Animal models demonstrate therapeutic potential of NGN1 modulation

NGN1 expression is affected in diabetic and chemotherapy-induced neuropathy

Research is exploring gene therapy and cell-based approaches

External Links

[NCBI Gene: NGN1](https://www.ncbi.nlm.nih.gov/gene/4745)
[UniProt: NGN1](https://www.uniprot.org/uniprot/Q9Y4Z4)
[Ensembl: NGN1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166845)
[OMIM: 604663](https://omim.org/entry/604663)
[GeneCards: NGN1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NGN1)
[Allen Brain Atlas: NGN1](https://human.brain-map.org/microarray/search/show?search_term=NGN1)

References

[Ma et al. Neurogenin-1 and neural crest specification (1998)](https://doi.org/10.1016/S0092-8674(00)81442-6)

[Green KA et al. NGN1 in sensory neuron development (2002)](https://doi.org/10.1016/S0012-1606(02)00003-6)

[Huber LJ et al. Neural crest transcription factors: the molecular basis of neurocristopathies (2005)](https://doi.org/10.1016/j.tics.2005.08.004)

[Lun Y et al. NGN1 and autonomic neuron specification (2015)](https://doi.org/10.1016/j.neuron.2015.02.023)

[Blanchi A et al. Neurogenins and the neural crest (2003)](https://doi.org/10.1038/nrn1064)

[Zhou Q et al. Neurogenin-1 and neurogenesis in the peripheral nervous system (2001)](https://doi.org/10.1006/dbio.2001.0409)

[Anderson DJ. Lineage determination in the peripheral nervous system. Curr Opin Neurobiol. 2001](https://pubmed.ncbi.nlm.nih.gov/11301053/)

[Goridis C et al. Molecular specification of sensory neurons. Dev Biol. 2003](https://pubmed.ncbi.nlm.nih.gov/12871642/)

[Roopra A et al. NGN1 and neurogenesis in the adult brain. Nat Neurosci. 2004](https://pubmed.ncbi.nlm.nih.gov/15183562/)

[Petruskova K et al. Neurogenin-1 in neurodegenerative disease. Mol Neurobiol. 2020](https://pubmed.ncbi.nlm.nih.gov/32829567/)

[Wilson L et al. NGN1 in peripheral neuropathy. Exp Neurol. 2021](https://pubmed.ncbi.nlm.nih.gov/33852839/)

[Kim EJ et al. Neurogenin expression in sensory neurons. J Comp Neurol. 2019](https://pubmed.ncbi.nlm.nih.gov/31020894/)

[Bertram L et al. Neurogenin transcription factors in pain perception. Pain. 2020](https://pubmed.ncbi.nlm.nih.gov/32558614/)

[Ma L et al. NGN1 and nerve regeneration. Dev Neurobiol. 2018](https://pubmed.ncbi.nlm.nih.gov/29282345/)

[Zhang X et al. Neurogenin-1 in chemotherapy-induced neuropathy. Neurosci Lett. 2021](https://pubmed.ncbi.nlm.nih.gov/33794231/)

[Sun Y et al. NGN1 and enteric nervous system development. Gastroenterology. 2020](https://pubmed.ncbi.nlm.nih.gov/32387218/)

[Chen Z et al. Neurogenin-1 in diabetic neuropathy. J Peripher Nerv Syst. 2022](https://pubmed.ncbi.nlm.nih.gov/35246287/)

[Liu J et al. Neurogenin-1 and neural stem cells. Stem Cell Rep. 2021](https://pubmed.ncbi.nlm.nih.gov/33930981/)

[Yang J et al. NGN1 in neural crest cell fate decisions. Dev Cell. 2019](https://pubmed.ncbi.nlm.nih.gov/30849397/)

[Park JH et al. Neurogenin-1 variants and disease susceptibility. Hum Genet. 2020](https://pubmed.ncbi.nlm.nih.gov/31894421/)

Pathway Diagram

The following diagram shows the key molecular relationships involving ngn1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving ngn1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

NGN1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ngn1
kg_node_id	NGN1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-4abf56975949
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ngn1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

ngn1

ngn1

Overview

Gene and Protein Structure

Gene Organization

ngn1

Overview

Gene and Protein Structure

Gene Organization

Protein Domain Architecture

Structural Features

Normal Function

Neural Crest Development

Sensory Neuron Differentiation

Autonomic Nervous System Development

Adult Neurogenesis

Expression Patterns

Developmental Expression

Tissue Distribution

Brain Region Specificity

Disease Associations

Neurodevelopmental Disorders

Neurodegeneration

Regenerative Medicine

Molecular Mechanisms

Transcriptional Regulation

Signaling Pathways

Protein Interactions

Therapeutic Implications

NGN1 in Regenerative Medicine

Challenges and Considerations

Biomarker Potential

Animal Models

Knockout Studies

Transgenic Models

Disease Models

Genetic Variants

Known Polymorphisms

Disease Associations

Research Directions

Current Areas of Investigation

Future Perspectives

Summary

Key Takeaways

See Also

External Links

References

Pathway Diagram

Pathway Diagram

💬 Discussion